focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnilever Regulatory News (ULVR)

Share Price Information for Unilever (ULVR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,316.00
Bid: 4,317.00
Ask: 4,318.00
Change: 36.00 (0.84%)
Spread: 1.00 (0.023%)
Open: 4,291.00
High: 4,325.00
Low: 4,289.00
Prev. Close: 4,280.00
ULVR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Unilever PLC Announces Directorate Change

28 Jul 2023 07:00

RNS Number : 4964H
Unilever PLC
28 July 2023
 

 

 

Appointment of Non-Executive Director and Chair Designate

London, 28 July 2023. Unilever PLC ("Unilever") is pleased to announce the appointment of Ian Meakins as a Non-Executive Director and Chair Designate following a comprehensive search process.

Ian will join the Board as Non-Executive Director and Chair Designate on 1 September 2023 and will succeed Nils Andersen as Chair on 1 December 2023. Nils will step down from the Board, after nine years' service, at Unilever's Annual General Meeting in May 2024.

Ian is currently Chair of Compass Group PLC and Rexel SA, and has significant global business experience across a diverse range of industries. He served as Chief Executive of Wolseley plc (now Ferguson plc) from 2009 to 2016, Chief Executive of Travelex Holdings Ltd from 2007 to 2009 and as Chief Executive of Alliance Unichem plc from 2004, until its merger with Boots in 2006. Previously he held positions at Diageo, Bain & Company, and Procter & Gamble.

Nils Andersen said: "I am delighted to welcome Ian to the Board following a thorough global search process. Ian has a strong track record of success in executive and non-executive roles across a range of industries. I am sure Unilever will greatly benefit from his extensive experience and I am confident that he will provide the Board with strong and effective leadership."

Ian Meakins said: "It is a great honour to have been asked to succeed Nils as Chair of Unilever. I look forward to working with the Board and with Hein and his leadership team to help realise Unilever's full potential and create value for all its stakeholders."

Hein Schumacher, Unilever CEO, said: "On behalf of the Board, I would like to thank Nils for his excellent leadership of our company as Chair over the last four years.

"Nils chaired the company through a period of significant volatility and some of the most challenging operational conditions in decades. He was instrumental in sharpening Unilever's focus on operational performance, creating a simpler and more agile company through the unification of Unilever NV and PLC into one legal structure, and implementing our new category focused organization."

There are no other matters that require disclosure under 9.6.13R of the UK Listing Rules.

ENDS

 

 

 

 

Enquiries

Media:

Jonathan Sibun +44 7779 999 683 / JSibun@tulchangroup.com

Lucila Zambrano +44 7825 273 767 / lucila.zambrano@unilever.com

 

Investors:

Investor Relations Team investor.relations@unilever.com

 

About Unilever  

Unilever is one of the world's leading suppliers of Beauty & Wellbeing, Personal Care, Home Care, Nutrition and Ice Cream products, with sales in over 190 countries and products used by 3.4 billion people every day. We have 127,000 employees and generated sales of €60.1 billion in 2022. 

Our vision is to be the global leader in sustainable business and to demonstrate how our purpose-led, future-fit business model drives superior performance. We have a long tradition of being a progressive, responsible business. 

The Unilever Compass, our global sustainable business strategy, is set out to help us deliver superior performance and drive sustainable and responsible growth, while aiming to: 

· improve the health of the planet;

· improve people's health, confidence and wellbeing;

· and contribute to a fairer and more socially inclusive world. 

For more information about Unilever and our brands, please visit www.unilever.com.

 

Safe Harbour 

This announcement may contain forward-looking statements, including 'forward-looking statements' within the meaning of the United States Private Securities Litigation Reform Act of 1995. Words such as 'will', 'aim', 'expects', 'anticipates', 'intends', 'looks', 'believes', 'vision', or the negative of these terms and other similar expressions of future performance or results, and their negatives, are intended to identify such forward-looking statements. These forward-looking statements are based upon current expectations and assumptions regarding anticipated developments and other factors affecting the Unilever Group (the 'Group'). They are not historical facts, nor are they guarantees of future performance or outcomes.

Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. Among other risks and uncertainties, the material or principal factors which could cause actual results to differ materially are: Unilever's global brands not meeting consumer preferences; Unilever's ability to innovate and remain competitive; Unilever's investment choices in its portfolio management; the effect of climate change on Unilever's business; Unilever's ability to find sustainable solutions to its plastic packaging; significant changes or deterioration in customer relationships; the recruitment and retention of talented employees; disruptions in our supply chain and distribution; increases or volatility in the cost of raw materials and commodities; the production of safe and high quality products; secure and reliable IT infrastructure; execution of acquisitions, divestitures and business transformation projects; economic, social and political risks and natural disasters; financial risks; failure to meet high and ethical standards; and managing regulatory, tax and legal matters. A number of these risks have increased as a result of the current war in Ukraine.

These forward-looking statements speak only as of the date of this announcement. Except as required by any applicable law or regulation, the Group expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Group's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

Further details of potential risks and uncertainties affecting the Group are described in the Group's filings with the London Stock Exchange, Euronext Amsterdam and the US Securities and Exchange Commission, including in the Annual Report on Form 20-F 2022 and the Unilever Annual Report and Accounts 2022.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASEWSFAEDSEEW
Date   Source Headline
24th Mar 20234:57 pmRNSDirector/PDMR Shareholding
24th Mar 20234:38 pmRNSTransaction in Own Shares
24th Mar 20234:30 pmRNSTransaction in Own Shares
24th Mar 20234:21 pmRNSTransaction in Own Shares
24th Mar 20232:50 pmRNSDirector/PDMR Shareholding
23rd Mar 20235:00 pmRNSTransaction in Own Shares
23rd Mar 202311:47 amRNSDirector/PDMR Shareholding
22nd Mar 20235:06 pmRNSTransaction in Own Shares
21st Mar 20234:52 pmRNSTransaction in Own Shares
20th Mar 20234:54 pmRNSTransaction in Own Shares
20th Mar 20232:59 pmRNSNotice of AGM
17th Mar 20235:06 pmRNSTransaction in Own Shares
17th Mar 20234:31 pmRNSDirector/PDMR Shareholding
17th Mar 20237:45 amRNSShare Buy-Back Programme
14th Mar 20234:06 pmRNSDirector/PDMR Shareholding
13th Mar 20236:20 pmRNSAnnual Report on Form 20-F
10th Mar 20235:47 pmRNSDirector/PDMR Shareholding
9th Mar 20236:22 pmRNSAnnual Financial Report
3rd Mar 202310:49 amRNSTotal Voting Rights
2nd Mar 20239:19 amRNSDirectorate Change
17th Feb 20234:38 pmRNSDirector/PDMR Shareholding
14th Feb 20235:51 pmRNSDirector/PDMR Shareholding
10th Feb 20236:03 pmRNSDirector/PDMR Shareholding
10th Feb 20234:49 pmRNSDirector/PDMR Shareholding
9th Feb 20237:00 amRNSFinal Results
2nd Feb 20231:22 pmRNSTotal Voting Rights
30th Jan 20237:00 amRNSDirectorate Change
13th Jan 202312:06 pmRNSPDMR Shareholding
4th Jan 202312:59 pmRNSTotal Voting Rights
20th Dec 20223:07 pmRNSPDMR Shareholding
19th Dec 20225:48 pmRNSDirector/PDMR Shareholding
19th Dec 20225:45 pmRNSShare Buyback Programme
19th Dec 20225:38 pmRNSTransaction in Own Shares
16th Dec 20226:05 pmRNSTransaction in Own Shares
15th Dec 20226:07 pmRNSTransaction in Own Shares
15th Dec 20225:35 pmRNSDirector/PDMR Shareholding
15th Dec 20223:04 pmRNSBlock listing of Shares
14th Dec 20226:12 pmRNSTransaction in Own Shares
13th Dec 20226:02 pmRNSTransaction in Own Shares
13th Dec 20223:59 pmRNSDirector/PDMR Shareholding
13th Dec 20222:40 pmRNSDirector/PDMR Shareholding
12th Dec 20225:51 pmRNSTransaction in Own Shares
12th Dec 202212:47 pmRNSDirector/PDMR Shareholding
9th Dec 20225:28 pmRNSTransaction in Own Shares
8th Dec 20226:14 pmRNSTransaction in Own Shares
7th Dec 20226:05 pmRNSTransaction in Own Shares
7th Dec 20224:54 pmRNSCapital Markets Day
6th Dec 20226:01 pmRNSTransaction in Own Shares
5th Dec 20225:53 pmRNSTransaction in Own Shares
2nd Dec 20226:10 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.